liraglutide


SMILES CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)O)CCC(=O)NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)O)CCCNC(=N)N)CCCNC(=N)N)C(C)C)CC(C)C)Cc1c[nH]c2c1cccc2)C)[C@H](CC)C)Cc1ccccc1)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1[nH]cnc1)N)C)CCC(=O)O)Cc1ccccc1)CO)CC(=O)O)CO)CO)Cc1ccc(cc1)O)CC(C)C)CCC(=O)O)CCC(=O)N)C)C
InChIKey YSDQQAXHVYUZIW-QCIJIYAXSA-N

Chemical properties

Hydrogen bond acceptors 49
Hydrogen bond donors 54
Rotatable bonds 130
Molecular weight (Da) 3748.9

Drug properties

Molecular type Protein
Physiological/Surrogate Surrogate
Approved drug Yes

Bioactivities

Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
GLP-1 GLP1R Human Glucagon B1 pKd 5.2 5.2 5.2 ChEMBL
GLP-1 GLP1R Human Glucagon B1 pKi 8.2 8.28 8.36 ChEMBL
Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
GLP-1 GLP1R Human Glucagon B1 pEC50 10.36 10.36 10.36 Guide to Pharmacology
GLP-1 GLP1R Human Glucagon B1 pIC50 8.32 9.14 9.96 ChEMBL
GLP-1 GLP1R Human Glucagon B1 pEC50 7.47 9.0 10.28 ChEMBL
GLP-1 GLP1R Human Glucagon B1 pEC50 7.99 7.99 7.99 Drug Central